Geert H Blijham

Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

G. Groenewegen, A. Griffioen, S. Martinotti, 1996, Cancer research.

Predictive value of signs and symptoms for colorectal cancer in patients with rectal bleeding in general practice.

J. Knottnerus, H. Schouten, J. Muris, 1995, Family practice.

Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer.

L. Collette, T. Conroy, M. Namer, 1997, European journal of cancer.

Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failure.

P. Rougier, C. Schmitt, E. Cutsem, 1999, Anti-cancer drugs.

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

E. Van Cutsem, C. Punt, P. Hérait, 1999, European journal of cancer.

Heat shock proteins in thermotolerance and other cellular processes.

E. Gerner, R. Miike, M. Wrensch, 1987, Cancer research.

Distress in MEN 2 family members and partners prior to DNA test disclosure. Multiple endocrine neoplasia type 2.

F. Beemer, G. Blijham, C. Lips, 2000, American journal of medical genetics.

An EORTC Gastrointestinal Group phase II evaluation of epirubicin combined with 5-fluorouracil in advanced adenocarcinoma of the pancreas.

O. Dalesio, A. Planting, N. Duez, 1987, European journal of cancer & clinical oncology.